World Hepatitis Day 2024: In-Depth Interview with Dr. S K Sarin Part - 2

Voice of Healthcare
28 Jul 202423:46

Summary

TLDRIn this insightful discussion, Dr. Serin highlights the global impact of viral hepatitis, particularly in India, emphasizing the urgent need for action. He outlines the importance of distinguishing between infection and disease, the effectiveness of treatments for Hepatitis B and C, and the significance of India's National Viral Hepatitis Control Program. Dr. Serin advocates for increased public awareness, testing, and treatment to combat the stigma and reduce the high mortality rates associated with these chronic infections. He also stresses the importance of a 'whole of society' approach to eliminate hepatitis by 2030, treating all infected individuals to prevent transmission and new infections.

Takeaways

  • 🌐 Globally, 96% of the 1.3 million hepatitis-related deaths are due to Hepatitis B and C, highlighting their significant impact on public health.
  • 💉 Vaccination and immunization are critical in combating viral hepatitis, especially since Hepatitis A and E can be cleared by the body, unlike the chronic infections of Hepatitis B and C.
  • 💊 Effective treatments exist for Hepatitis B and C, with Hepatitis C having a cure rate of 90-95% within 12 weeks using oral medications.
  • 🇮🇳 India has a National Viral Hepatitis Control Program offering free testing, treatment, and monitoring for Hepatitis C, a privilege few countries provide.
  • 🚫 The mindset of infected individuals often leads to unnecessary fear and avoidance of normal life activities, despite the fact that infection does not equate to disease.
  • 📉 The risk of cirrhosis and liver cancer significantly decreases with proper treatment of Hepatitis B and C.
  • 📈 Awareness and early detection are crucial for reducing hepatitis-related deaths, emphasizing the need for public education and participation.
  • 📊 India's National Viral Hepatitis Control Program, despite being well-structured, requires more visibility and public engagement to be fully effective.
  • 🌟 Celebrity involvement in awareness campaigns, similar to those for TB, could significantly boost public understanding and empathy towards hepatitis.
  • 🏥 The healthcare system and government need to prioritize hepatitis prevention, screening, and treatment, especially in resource-constrained settings.
  • 🎯 The goal is to eliminate hepatitis by 2030, which requires a whole-of-society approach, including education, testing, and treatment for all infected individuals.

Q & A

  • What is the global status of viral hepatitis, particularly in India?

    -Viral hepatitis, particularly Hepatitis B and C, is a significant public health issue with 96% of the 1.3 million deaths due to hepatitis being caused by these two types. India has a National Viral Hepatitis Control Program since 2018, which provides free testing, treatment, and monitoring for Hepatitis C.

  • What is the difference between Hepatitis A, B, C, and D in terms of infection persistence?

    -Hepatitis A and E are typically cleared by the body, while Hepatitis B, C, and D are chronic infections that persist for life unless treated. Hepatitis B treatment aims to suppress the virus, similar to HIV, with clearance being rare.

  • What is the significance of the theme 'Time to take action against hepatitis'?

    -The theme emphasizes the urgency to increase awareness, improve screening, and ensure treatment accessibility to combat the high mortality rate associated with Hepatitis B and C.

  • How effective are the current treatments for Hepatitis B and C?

    -For Hepatitis C, there are very effective drugs that can clear the virus within about 12 weeks, with a 90-95% clearance rate. Hepatitis B treatment involves daily medication to suppress the virus, significantly reducing the risk of cirrhosis and liver cancer.

  • What is the importance of distinguishing between being infected with Hepatitis B and having the disease?

    -It's crucial to differentiate because only 1 to 10% of those infected will develop the disease. Many infected individuals may not show symptoms and can live normal lives if the virus is suppressed with treatment.

  • Why is awareness and testing for Hepatitis C important, especially for certain groups?

    -Awareness and testing are important because Hepatitis C can be asymptomatic yet lead to severe liver damage or cancer. High-risk groups such as those who have received blood transfusions, IV drug users, and individuals who have undergone surgery should get tested.

  • What is the role of the Indian government in combating viral hepatitis?

    -The Indian government has established a National Viral Hepatitis Control Program that offers free hepatitis C drugs, testing, and monitoring. The program aims to increase visibility and awareness to reduce the stigma and improve public participation.

  • How can public figures and celebrities contribute to raising awareness about hepatitis?

    -Public figures like actors can have a significant impact on raising awareness by participating in campaigns, sharing their personal experiences, and advocating for the importance of testing and treatment.

  • What are the challenges faced by the National Viral Hepatitis Control Program in India?

    -While the program provides free services, challenges include low public participation, lack of awareness, and the stigma associated with hepatitis, which hinder early detection and treatment.

  • What is the significance of the 'WOM' program in hepatitis awareness?

    -The 'WOM' program involves women who are hepatitis positive becoming ambassadors to educate and support others. Their personal experiences make them effective in spreading the message and reducing fear and stigma.

  • What are the future aspirations for hepatitis care and management globally?

    -The aspiration is to treat all infected individuals, not just those with the disease, to reduce the pool of potential transmitters. This approach aims to eliminate hepatitis by the end of the century, ensuring future generations are free from hepatitis B and C.

Outlines

00:00

🌏 Global Status of Viral Hepatitis and Public Health Impact

The speaker discusses the global status of viral hepatitis, particularly in India, emphasizing the significant impact on public health. They highlight that 96% of the 1.3 million hepatitis-related deaths are due to hepatitis B and C, which are chronic infections that the body cannot clear without treatment. The speaker underscores the importance of vaccination and treatment, noting that effective drugs for hepatitis C can cure the infection within 12 weeks and significantly reduce the risk of cirrhosis and liver cancer. They also mention India's national viral hepatitis control program, which offers free testing, treatment, and monitoring, and stress the need for increased awareness and action to combat the disease.

05:00

📢 Raising Awareness and National Control Programs

This paragraph focuses on the need for greater visibility and awareness of hepatitis B, comparing its death rate to that of tuberculosis and malaria. The speaker advocates for strong public campaigns to educate about hepatitis, similar to those that have been successful for other diseases. They discuss India's National Viral Hepatitis Control Program, noting that while the government has provided free drugs and testing, public participation is lacking. The speaker calls for increased testing among high-risk groups and emphasizes the importance of early detection and treatment to prevent advanced liver disease and cancer.

10:05

👩‍🏫 Education and Community Outreach for Hepatitis Awareness

The speaker discusses the importance of education and community outreach in raising awareness about hepatitis. They mention a program called 'WOM' where women who are positive for hepatitis B become ambassadors to educate others. The speaker encourages listeners to educate others about the disease and to dispel myths about transmission. They also highlight the need for healthcare professionals to be vigilant about potential transmission in clinical settings and the importance of early treatment to prevent the progression to more severe conditions.

15:05

💉 Vaccination and Treatment Options for Hepatitis

The paragraph delves into the availability of vaccines for hepatitis B and the lack of a vaccine for hepatitis C. It mentions the inclusion of the hepatitis B vaccine in the national immunization schedule for newborns and the availability of catch-up schedules for adults. The speaker addresses the absence of a hepatitis C vaccine but notes the existence of effective treatments, such as direct-acting antivirals, which can cure the infection in most cases. They also discuss the importance of testing for hepatitis C, especially for those who have undergone surgeries or procedures where there may have been a risk of exposure.

20:06

🌟 Future Aspirations for Hepatitis Management

The speaker shares their aspirations for the future of hepatitis care and management, advocating for a shift from selective treatment to treating all infected individuals to prevent further transmission. They express hope that by 2030, a global approach similar to that for HIV will be adopted for hepatitis B and C, treating all infected individuals regardless of whether they show symptoms of the disease. The speaker envisions a future where new generations are free from hepatitis B and C, thanks to widespread vaccination and treatment.

Mindmap

Keywords

💡Viral Hepatitis

Viral Hepatitis refers to a group of infectious diseases that affect the liver, caused by viruses. In the context of the video, it is a significant public health issue, particularly in India, where the focus is on combating Hepatitis B and C. The video discusses the global status and impact on public health, emphasizing the need for critical actions such as vaccination and treatment to effectively control the spread of the disease.

💡Hepatitis B and C

Hepatitis B and C are the two most common types of viral hepatitis that lead to chronic infections. As mentioned in the script, 96% of the 1.3 million hepatitis-related deaths globally are due to these two types. The video highlights the importance of distinguishing between infected and diseased patients and the effectiveness of treatments available for both conditions, especially Hepatitis C, which can be cured within 12 weeks with the right medication.

💡Vaccination

Vaccination is a crucial preventive measure against viral hepatitis, specifically Hepatitis B. The script emphasizes the need for immunization, as it is one of the most effective ways to prevent the spread of the disease. The World Health Organization's strategy includes increasing vaccination coverage as a key measure to combat viral hepatitis [^1^].

💡Treatment

Treatment for viral hepatitis, especially for Hepatitis B and C, is discussed in the video as an essential component of managing the disease. For Hepatitis B, treatment involves virus suppression, while Hepatitis C can be cured with antiviral drugs within a few months. The script mentions that India has a national program providing free testing and treatment for Hepatitis C, highlighting the importance of public awareness and access to these treatments.

💡Public Health Impact

The impact of viral hepatitis on public health is a central theme of the video. It discusses the global status of the disease, particularly in India, where the burden of Hepatitis B and C is significant. The script underscores the need for awareness and action to reduce the disease's impact, including the importance of early detection, screening, and treatment.

💡Chronic Infections

Chronic infections, such as those caused by Hepatitis B and C, persist for a lifetime unless treated. The script explains that unlike Hepatitis A and E, which the body can clear, Hepatitis B and C require lifelong treatment or can be cured with the right medication. This concept is important for understanding the long-term management and public health implications of viral hepatitis.

💡Awareness

Raising awareness is highlighted in the script as a critical action needed to combat viral hepatitis. The video discusses the importance of educating the public about the disease, its transmission, prevention, and treatment options. It also emphasizes the need to challenge stigma and misconceptions about the disease to encourage people to get tested and treated.

💡National Viral Hepatitis Control Program

The script mentions India's National Viral Hepatitis Control Program, which was launched in 2018 to provide free testing, treatment, and monitoring for Hepatitis C. This program is an example of a government initiative aimed at reducing the disease's burden and improving public health outcomes for those affected by viral hepatitis.

💡Stigma

Stigma associated with viral hepatitis is discussed in the script as a significant barrier to testing and treatment. The video talks about the negative mindset and social implications for those infected, which can lead to isolation and reluctance to seek help. Addressing this stigma is crucial for encouraging people to get tested and treated and for promoting a better understanding of the disease.

💡Prevention

Prevention measures for viral hepatitis, including vaccination and safe practices such as avoiding risky behaviors that can lead to infection, are discussed in the script. The video emphasizes the importance of early detection and prevention to reduce the disease's spread and improve overall public health.

Highlights

Global status of viral hepatitis, particularly in India, and its significant impact on public health.

96% of 1.3 million hepatitis-related deaths are due to hepatitis B and C, which are chronic infections.

Hepatitis B treatment aims to suppress the virus, with clearance being rare, similar to HIV.

The importance of differentiating between infected and diseased patients in the context of hepatitis.

Hepatitis C can be cured with very effective drugs within about 12 weeks.

India's National Viral Hepatitis Control Program offers free testing, treatment, and monitoring since 2018.

The need for increased public awareness and participation in combating hepatitis.

The importance of testing for hepatitis C, especially among high-risk groups.

The role of Hepatitis B in causing liver cancer and the need for early treatment.

The potential of using public figures like Amitabh Bachan to raise awareness about hepatitis.

The progress and challenges of the National Viral Hepatitis Control Program in India.

The need for better prioritization of hepatitis prevention, screening, and treatment in healthcare systems.

The importance of early detection and treatment in reducing liver cancer risks associated with hepatitis B and C.

The role of women as ambassadors in raising awareness and combating hepatitis, especially among women who are hepatitis B positive.

The aspiration for a global shift towards treating all hepatitis B and C patients by 2030.

The importance of vaccination for hepatitis B and the absence of a vaccine for hepatitis C.

The future hopes for the elimination of hepatitis, with a focus on early detection, treatment, and vaccination.

Transcripts

play00:01

[Music]

play00:22

so um since we're talking about

play00:23

hepatitis can you share a global status

play00:26

of viral hepatitis particularly in India

play00:28

and its impact on Public Health what are

play00:31

the most critical action needed to

play00:33

combat viral hepatitis effectively like

play00:36

we talked you said the vaccination

play00:38

immunization is required and because we

play00:41

talking about for this year's theme is

play00:44

time to take action time to take action

play00:46

against hepatitis to protect our

play00:50

world yes uh hepatitis 96% of the deaths

play00:56

of the 1.3 million deaths which which

play01:00

occur due to Hepatitis B and C are of

play01:04

all the hepatitis deaths 96% are because

play01:07

of hepatitis B and C let me tell you a

play01:11

important

play01:12

part uh the bloodborn viruses B and C

play01:16

are chronic infections chronic means

play01:20

body cannot clear them Hepatitis A and E

play01:24

they are cleared by body but B and C and

play01:27

D they persist for your life life unless

play01:31

treated Hepatitis B the treatment is to

play01:34

suppress the

play01:37

virus clearance is rare like in

play01:40

HIV so in Hepatitis B if you give the

play01:44

drug it will supress the virus but if

play01:47

your virus is suppressed you're as good

play01:49

as anybody and we therefore need to

play01:51

differentiate infected from diseased

play01:55

patients so 30 million are infected Ed

play02:00

but the disease will occur in 1 to 10%

play02:03

of

play02:04

them but the the mindset of the

play02:08

remaining is so bad that they feel that

play02:11

oh something has happened I got two

play02:13

patient subjects yesterday one was 32

play02:16

years a lady and one was a boy who was

play02:18

37 both had not

play02:20

married because they thought they are

play02:23

sick so it is so important for us to say

play02:26

we have so many

play02:28

infections so having an infection is not

play02:32

equivalent to

play02:52

disease I would say for Hepatitis B and

play02:55

C for policy matters hepatitis C is

play02:58

treated by drugs we have very effective

play03:01

drugs they can clear cure you of the

play03:05

hepatitis C in about 12 weeks time they

play03:08

are oral drugs you take a pill a day for

play03:11

3 months finished and 90 95% clearance

play03:16

if you have hepatitis C and if you get

play03:18

the drugs then chances of curosis liver

play03:22

cancer all of them decrease and good

play03:25

part is India has a national viral

play03:27

hepatitis control program from 2018 now

play03:31

it will be 6 years and nadas sa had

play03:33

launched it at that time and it is free

play03:36

hepatitis C drugs are free very few

play03:39

countries in the India in the world have

play03:42

this privilege for patients the testing

play03:44

is free the treatment monitoring

play03:48

everything is free so if you know of

play03:50

somebody who has hepatitis C please help

play03:52

them our Hepatitis B the treatment is

play03:56

effective you take a pill a day the

play03:58

yearly cost may not be more than 4,000

play04:01

rupees or so and the virus is suppressed

play04:04

then you are as good as anybody the risk

play04:06

of curosis the risk of liver cancer

play04:09

significantly decreases so what we need

play04:12

to do is to take it in your hands don't

play04:16

depend always on doctors or on the

play04:19

governments or policies decide if I have

play04:22

Hepatitis B I must get rid of it if not

play04:25

get the virus suppressed if I have

play04:27

Hepatitis C I will get it cured because

play04:29

they are effective drugs I will not let

play04:32

have my body go to the stage of curosis

play04:35

or cancer and even if it occurs you have

play04:38

transplant you have every possibility so

play04:41

the deaths can be reduced but by

play04:43

awareness but if you are

play04:44

late then like blood vit or jaundice and

play04:48

others then it is a different situation

play04:51

now the next part of your thing is about

play04:55

the

play04:57

policies I think India is amongst the

play05:00

very few countries despite being so

play05:02

large is to have a powerful National

play05:05

viral hepatitis control program but it

play05:08

needs to be more you know visible like

play05:12

my my desire is like the Prime Minister

play05:17

sometimes says for

play05:19

TB the number of deaths due to Hepatitis

play05:22

B are no less maybe more in fact the who

play05:26

says every 30 seconds there is a person

play05:29

who is dying due to Hepatitis B so like

play05:31

in last 20 minutes 40 people have died

play05:34

due to Hepatitis B somewhere in the

play05:37

world and the number of deaths due to

play05:39

Hepatitis B are not less than combined

play05:44

deaths by TB and malaria so you put TB

play05:47

and malaria where we have more

play05:50

visibility why not more visibility more

play05:53

awareness like your campaign for

play05:56

Hepatitis B and trying to eliminate it

play06:00

and also the empathy to you know support

play06:05

them is absolutely necessary we have to

play06:08

eliminate we just don't have to control

play06:10

have to get rid of it we have to do that

play06:12

sir and Sir like you mentioned how uh

play06:16

prime minister emphasizes on TB and more

play06:19

than that more deaths happens because of

play06:21

hepatitis so I think I was very small I

play06:24

I still remember that people got more of

play06:26

awareness about TV in fact of when I was

play06:29

78 or 10 years around I got to know

play06:31

about TV how because of a public

play06:33

advertisement Mr amitab batan uh was

play06:36

into a public awareness campaign

play06:39

advertisement in which he talked about

play06:40

TV how it is transmitted what other the

play06:44

solutions we have and stuff like that I

play06:46

think these kind of strong campaigns we

play06:49

need for hepatitis as well that can

play06:52

raise awareness on this and you know can

play06:54

uh can make more aware people about this

play06:57

absolutely and as doctors like you we

play06:59

have in our country that is great but

play07:02

more than that I believe people watch

play07:04

more of actors and then they make impact

play07:07

on people got the right person amitab

play07:09

bachan has Hepatitis B exactly and he

play07:12

did a campaign once or twice so will you

play07:15

go to him and tell him again you go to

play07:17

amitab batan G and then say Sir one more

play07:20

time and every time and be with people

play07:23

let us see the elimination part in case

play07:26

he's hearing or has some approach on

play07:28

this video I think it will he is one of

play07:32

the best you know known persons and his

play07:35

voice would make a difference truely sir

play07:38

thank you so we also talked about

play07:41

National viral hepatitis control program

play07:45

uh in along with that I want to know the

play07:48

views on that and how far it has

play07:50

progressed and what necessary steps

play07:52

needs to be taken to combat hepatitis to

play07:55

achieve Countrywide elimination of

play07:57

hepatitis C by 2030 which is the program

play08:00

aims for and how can healthare system

play08:02

and government better

play08:04

prioritize hepatitis prevention

play08:06

screening and treatment especially in

play08:08

resource oriented constraint settings

play08:11

well hepatitis C I think the government

play08:14

did

play08:16

everything uh they provided the drugs I

play08:19

know that they have not been adequately

play08:22

used by people uh the screening the

play08:26

virus the RNA everything is free what is

play08:29

lacking is the public

play08:31

participation yeah what is lacking is we

play08:35

hardly have you know 10 to 15% of the

play08:38

infected India has 7 million lakh

play08:43

estimate and we have hardly treated

play08:45

maybe few

play08:47

lcks so I would like to say that the

play08:51

testing the knowledge about hepatitis C

play08:54

is very important all those who got

play08:57

vaccination like small pox and others

play08:59

all diabetics who get injections all

play09:02

those who are

play09:04

repeatedly using drugs IV drug users and

play09:09

they share their needles and syringes

play09:12

all that group must be tested I already

play09:15

told you that hepatitis C testing should

play09:18

also be done in those with dialysis

play09:20

those who got blood transfusion before

play09:22

99 or maybe even 2005 till then the

play09:26

blood banks were not very effective our

play09:28

testings were not so I would say uh this

play09:30

is called

play09:32

recall then all blood banks who find

play09:35

anybody positive for BNC should inform

play09:37

the person that please come and get

play09:39

tested all these are part of the viral

play09:42

hepatitis control program but the public

play09:45

participation for that needs to be

play09:48

energized and through interviews like

play09:50

you siman it will make a difference for

play09:53

Hepatitis B I already told you high risk

play09:55

groups so ensure if you are listening

play09:59

this ensure if your friends are probably

play10:05

susceptible pass this message each one

play10:08

of you please listen and educate 10 and

play10:11

that person should educate another 10

play10:13

and all these schools should have a

play10:16

competition maybe for a week yesterday

play10:19

we had a competition here almost 200

play10:22

students participated you will be amazed

play10:24

their knowledge they knew all about wh

play10:27

guidelines of 2024 a sixth class student

play10:31

made a rubic you know puzzle using rubic

play10:36

cubes on hepatitis so what I'm saying is

play10:39

each one of you who is listening uh go

play10:43

down to the school levels and don't be

play10:46

scared you know it hepatitis BNC they

play10:49

don't come by eating together or shaking

play10:52

hands and all that

play10:54

or so don't be scared get treated body

play10:58

FL one must remember like if you are

play11:02

infected sometimes saliva has lot of

play11:05

hepatitis B not C too much or your if

play11:09

you have an injury and you're positive

play11:10

it is and any Doctor Who is Hepatitis B

play11:14

should definitely disclose to the

play11:16

patient or get virus negative before you

play11:19

know he can transmit the virus so these

play11:22

are some of the tips that I have given

play11:24

you the viral hepatitis control program

play11:27

in India has been you know somewhat it

play11:30

was our own ilbs was lucky to be as a wh

play11:34

Center to help in the conception to

play11:37

creation and now we feel that the

play11:40

government has done very well but uh the

play11:44

public

play11:45

participation awareness the stigma they

play11:49

are the bigger blocks and we have to

play11:52

overcome we started a program called wom

play11:56

wom is women who are he is be positive

play12:01

women who are positive become the

play12:04

ambassadors suppose I am a woman and I

play12:07

am Hepatitis B positive I would not go

play12:10

and tell my husband the baby is born I'm

play12:13

so scared because you go for anal

play12:15

checkup in a clinic and they say your

play12:18

hepatitis be positive now this woman

play12:20

cannot go home she is so

play12:26

scared such women those who have

play12:29

survived all this then we have been

play12:32

running it for almost now 20 years this

play12:36

program and these uh women are made as

play12:40

an

play12:40

ambassador 100 200 of them will go and

play12:43

say don't worry this is not your problem

play12:46

but if you are talking to everyone you

play12:48

may save many many more and their family

play12:52

lives can improve so it is a whole of

play12:54

society

play12:55

approach the infection is deadly the

play12:58

infection is problematic the infection

play13:01

is a cause of concern but if we are

play13:04

standing together and our message is

play13:08

clear I think so they are the best

play13:10

people to spread message because they

play13:12

have experienced it they have gone

play13:14

through it gone through it and they have

play13:16

lived the agony they have lived the

play13:18

despair the

play13:20

isolation you know we we have a study

play13:23

called beat b how do you beat the

play13:26

Hepatitis B because people come and

play13:28

doctors say say no no you come after one

play13:30

year because you're not fit to take

play13:32

treatments I'm trying to get the

play13:33

guidelines Chang because you ask the

play13:35

agony of the patient his isolation he

play13:39

can't

play13:44

sleep B is a DNA

play13:55

virus and disease disease treatment work

play13:59

treatment

play14:02

orus and it is gone and you have a

play14:05

strong mind all those who have not

play14:07

married find someone if the spouse

play14:11

likely spouse has any issues doctors

play14:13

like me will solve this problem but get

play14:15

married in

play14:18

24 latest by

play14:22

25 great okay so since we're talking

play14:25

about suppressing the hepatitis and we

play14:28

don't talked about all the types of

play14:30

hepatitis we have a b c d and e so uh I

play14:36

have few question regarding vaccinations

play14:39

one do we have vaccination for all these

play14:41

five hepatitis second you talked about

play14:44

immunization and vaccinations and how we

play14:47

can eradicate through vaccinations so do

play14:51

actually the vaccination card the plan

play14:52

of a newborn baby when when the baby is

play14:54

born they get in 2 months 3 months and

play14:57

every month they have scheduled some

play14:58

vaccines so so does that also include

play15:00

the hepatitis yes it does include

play15:02

Hepatitis B in fact it is part of the

play15:05

National schedule and now there are new

play15:08

five in one pentavalent vaccines have

play15:10

come which included again dpia whatever

play15:13

meil so all these vaccines are part of

play15:16

the National schedule and the cards are

play15:18

given even for adults you will have 013

play15:21

016 schedule is available and uh the

play15:27

vaccine especially Healthcare workers

play15:29

should get their antibody done not rest

play15:31

of the population that is done now

play15:34

hepatitis C since you asked does not

play15:36

have a vaccine okay B has a vaccine a

play15:40

has a vaccine but not C it's a difficult

play15:44

RNA virus like Corona it was so

play15:46

difficult but that was a global Calamity

play15:48

so people developed now they're working

play15:50

on a mRNA vaccine for

play15:53

C but C the good part is that it is

play15:57

generally quiet and the treatable

play16:00

curable the bad part is that people are

play16:03

not aware like for example people got

play16:05

cesarian sections they got hysterctomy

play16:09

or they got a prostate surgery long ago

play16:12

now they are coming with Advanced liver

play16:15

disease due to hepatitis C or a cancer

play16:18

due to Hepatitis C so one more time

play16:20

anybody who's got a surgery or a

play16:22

procedure done anytime I would say don't

play16:25

worry about 99 or 2005 do get your

play16:28

hepatitis C test if it is the RNA is

play16:31

positive get treated on that the

play16:35

hepatitis A vaccine is uh given in all

play16:40

the countries developed countries but in

play16:43

India generally the kids have Hepatitis

play16:46

A by food and water so they are already

play16:48

immunized hepatitis A the immunity is

play16:51

lifelong

play17:00

but now wealth is there in India

play17:03

everywhere so they all carry their

play17:04

bottles and they don't drink and hygiene

play17:08

Theory I would say hepati is a vaccine

play17:10

in those who are somewhat Middle High

play17:14

upper middle or Rich class they should

play17:15

get the vaccine done foreigners

play17:18

Travelers they get Hepatitis A vaccine

play17:21

Hepatitis E vaccine is not there so we

play17:24

have to be careful that in Winters and

play17:26

other things we have good proper hype

play17:28

portable good drinking water and food is

play17:31

not exposed and handled by poor people

play17:34

so you

play17:35

protect I those are very handy dips

play17:38

which we can take the time okay so and

play17:42

uh what are the options available

play17:44

available for people who are diagnosed

play17:46

with Hepatitis B and C the treatments

play17:48

available like you said a we all are

play17:51

immunized by our birth if a person gets

play17:53

them and B we also have but C is

play17:57

something yeah see the drugs are

play17:59

available there are two drugs SOS and

play18:03

wellas it comes as or DEET these are the

play18:06

drugs they are given in the National

play18:09

program also at least soft and DEA and

play18:12

by taking that your 90% chance of

play18:15

getting rid of the virus and uh the

play18:19

drugs are not expensive India has some

play18:21

of the cheapest the best generic

play18:23

medication uh Pharmacy and hepatitis B

play18:26

drugs are tenob t and Ana these drugs

play18:30

are available and they are genetics are

play18:34

very cheap in fact India exports to

play18:36

every country and they are safe so all

play18:40

these drugs are generally safe but I

play18:42

would say we do see in a given week and

play18:45

in India the liver cancers due to B andc

play18:48

are is still a problem if patient has

play18:50

curosis he needs a treatment for liver

play18:52

disease with a specialist care and if

play18:56

there is a cancer then also specialist

play18:58

care sometimes you require transplant

play19:01

for BNC which is readily done very

play19:04

successful programs so I think those who

play19:07

have an advanced disease are uh treated

play19:10

in a specialized Center but our aim is

play19:13

early detection early screening and uh

play19:17

you know treating them early enough and

play19:20

preventing those by proper vaccination

play19:23

if we take these steps clearly and

play19:27

policies which are very clear are

play19:29

adopted uh by all stakeholders whether

play19:32

you drug user or dialysis groups and

play19:36

others I think we can prevent hepatitis

play19:38

C we should be able to eliminate maybe

play19:41

if not 2030 uh within the next few years

play19:44

or so but those who are hidden the

play19:47

biggest problem is where are those

play19:54

people so going ahead we have come to

play19:58

end of this awareness program I want to

play20:02

know your views your hopes and

play20:04

aspirations for the future of hepatitis

play20:06

care and management both in India and

play20:08

globally you just told us uh you know

play20:11

diagnosing them making them people will

play20:13

identify who are they treating them

play20:15

eradicating it but the aspirations ahead

play20:17

for

play20:18

that yeah actually Hepatitis B has been

play20:22

treatment has been Complicated by

play20:26

doctors uh they make guidelines whom to

play20:29

treat and whom not to treat this guy has

play20:33

fibrosis so he should be treated his DNA

play20:36

is high he should be treated his liver

play20:39

has inflammation like his sgbt is high

play20:41

he should be treated others are just

play20:44

watched because they know that out of

play20:46

100 people maybe 10 will have disease so

play20:49

they want to treat the disease they do

play20:52

not want to treat the

play20:54

infected but my opinion is different and

play20:58

my my opinion is that the infected will

play21:01

give the infection to others and every

play21:04

year several lacks of new Hepatitis B

play21:07

are detected I mean infected so in my

play21:11

opinion all infected and all diseased

play21:15

all of them should be treated so my

play21:18

Approach is from treat

play21:20

select to treat all yeah and this I have

play21:25

been proposing for last 4 years or so

play21:27

and I'm happy to say that the Chinese

play21:31

associations have moved a little bit

play21:33

that side wh has moved a little towards

play21:36

this side and my feeling my aspiration

play21:39

is by 2030 globally like HIV where we

play21:43

treat

play21:44

all we will treat all for Hepatitis B we

play21:49

treat all hepatitis C we don't isolate

play21:52

you have the virus but no disease we

play21:54

treat whether you have infected or

play21:57

infected plus disease

play21:59

in Hepatitis B also we should treat the

play22:02

infected and anybody who Hepatitis B

play22:05

positive and those who are diseased both

play22:08

together so that the pool of infected

play22:11

and the pool who are carrying the virus

play22:13

to transmit it to the others disappears

play22:16

if we take this

play22:18

policy we will require 65 years more or

play22:23

70 years more to get rid of heati by end

play22:26

of this Century we can be called because

play22:29

all newborns will be protected yes and

play22:32

all infected will be treated and average

play22:34

age of Indian is 70 years so you require

play22:37

a complete new generation of Indians who

play22:40

are free of hepatitis B they are living

play22:43

without fear of B or C and then there's

play22:47

no scope of hepatitis yes no scope you

play22:51

are immunized you're vaccinated

play22:54

finished okay that's great sir thank you

play22:57

so much Dr serin for for your valuable

play22:59

insights your contribution you have made

play23:01

to this campaign of public Awareness on

play23:04

the occasion of world hepatitis day it

play23:06

matters a lot because all these uh tips

play23:09

treatment options uh future plans are

play23:12

coming from the expert of this field so

play23:15

thanks a lot for your time and your

play23:17

valuable Insight it matters a lot thank

play23:19

you siman and thank you Shas both of you

play23:22

for coming here and it's a pleasure I

play23:24

hope through you the message goes and if

play23:27

there is something wrong with I have

play23:28

said get back to me and say Doc you're

play23:31

wrong here doc you should improve I'm

play23:34

ready but I committed sure sir thank you

play23:37

thanks a lot thank you

Rate This

5.0 / 5 (0 votes)

関連タグ
Viral HepatitisPublic HealthIndiaPreventionAwarenessTreatmentImmunizationHealth CampaignExpert OpinionWorld Hepatitis DayHealthcare Policy
英語で要約が必要ですか?